Purpose: The urokinase plasminogen activator (uPA) and its receptor (uPAR) are expressed by pancreatic cancer cells and can be targeted by the plasminogen activator inhibitor type 2 (PAI2). We have labeled PAI2 with 213Bi to form the alpha conjugate (AC), and have studied its in vitro cytotoxicity and in vivo efficacy.
QU C.F.;
SONG E.;
LI Y.;
RIZVI S.M.A.;
RAJA C.;
ROSS R;
APOSTOLIDIS Christos;
ALLEN Barry J.;
MORGENSTERN Alfred;
2007-01-15
SPRINGER
JRC33606
https://publications.jrc.ec.europa.eu/repository/handle/JRC33606,
| Name | Country | City | Type |
|---|
This document is only visible at the Commission level.
You are not authorized to publish or distribute it outside the European Commission.
This is a public document. You can share this publication.
Datasets
| ID | Title | Public URL |
|---|
Dataset collections
| ID | Acronym | Title | Public URL |
|---|
Scripts / source codes
| Description | Public URL |
|---|
Additional supporting files
| File name | Description | File type |
|---|